HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 173,252 | $6,249,200 | 0.00% |
| Spire Wealth Management | 500 | $18,035 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,156 | $185,977 | 0.00% |
| SG Americas Securities, LLC | 3,645 | $131 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1,767 | $63,733 | 0.00% |
| CULLEN/FROST BANKERS, INC. | 1,000 | $36,070 | 0.00% |
| FRANKLIN RESOURCES INC | 77,097 | $2,780,888 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 126,773 | $4,572,702 | 0.00% |
| BROWN ADVISORY INC | 20,811 | $750,653 | 0.00% |
| Creative Planning | 13,470 | $485,863 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 15,869 | $572 | 0.00% |
| MACKENZIE FINANCIAL CORP | 10,223 | $377,024 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 20,468 | $738,280 | 0.00% |
| PICTET ASSET MANAGEMENT SA | 15,982 | $576,471 | 0.00% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 17,952 | $647,529 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 812 | $29,289 | 0.00% |
| Empower Advisory Group, LLC | 7,387 | $266,449 | 0.00% |
| Park Place Capital Corp | 146 | $5,266 | 0.00% |
| LPL Financial LLC | 38,382 | $1,384,451 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 7,218 | $260 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.